Pharmaceutical Technology Europe
August 02, 2019
30th Anniversary Coverage
31
8
As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.
August 02, 2019
From the Editor
31
8
Pharmaceutical Technology Europe celebrates 30 years in publishing the latest insights, analysis, and developments of the bio/pharma industry.
August 02, 2019
30th Anniversary Coverage
31
8
The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.
August 02, 2019
30th Anniversary Coverage
31
8
Rapid change towards industry developing and manufacturing niche APIs is leading to smaller-scale facilities that offer higher containment and flexibility.
August 02, 2019
30th Anniversary Coverage
31
8
To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.
August 02, 2019
30th Anniversary Coverage
31
8
Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.
August 02, 2019
30th Anniversary Coverage
31
8
Harmonization of regulatory guidelines not only reduces workloads for manufacturers and regulators but can potentially help to accelerate patient access to vital therapies.
August 02, 2019
30th Anniversary Coverage
31
8
Instrumentation advancements over the past 30 years have certainly enabled greater efficiency in pharma development and analysis despite slow adoption by the industry.
August 02, 2019
30th Anniversary Coverage
31
8
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
August 02, 2019
30th Anniversary Coverage
31
8
To deal with the complex requirements of biopharmaceuticals, companies need a sophisticated toolbox of analytical and purification techniques.
August 02, 2019
Features
31
8
European Union regulators have taken a significant step towards resolving some of the major supply-chain difficulties behind medicine shortages.
August 02, 2019
30th Anniversary Coverage
31
8
Machine vision systems have been an integral part of pharma manufacturing and packaging for many years and, with the introduction of stricter safety regulations, are set to become more vital.
August 02, 2019
Anniversary Issue Focus
31
8
Much has changed in the bio/pharma industry over three decades. In this special feature, the editors take a trip down memory lane, highlighting some of the major happenings of the past 30 years.
August 02, 2019
Features
31
8
Europe has introduced a waiver for supplementary protection certificates, polarizing opinions throughout the industry. In this interview, the SPC waiver and its implications for European pharma are discussed.
August 01, 2019
Issue PDF
31
8
Click the title above to open the Pharmaceutical Technology Europe August 2019 issue in an interactive PDF format.